Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information.
Company Website: http://www.stereotaxis.com/
Stereotaxis (NASDAQ: STXS) Stock Message Board
2285 | Sponsor | 04/19/2024 3:23:51 PM | |
6 | $STXS breakout candle. Nasdaq GM | PoemStone | 02/08/2015 6:54:30 PM |
5 | Latest Stereotaxis (STXS) Headlines 20.2% Return | Stock_Tracker | 03/13/2014 3:02:41 AM |
4 | STXS Stock Charts Last: +0.08 Thursday, February | chartguy89 | 02/27/2014 10:34:26 AM |
3 | ST. LOUIS, Oct. 23, 2013 (CRWE Press | karnacua2 | 10/23/2013 12:50:03 PM |
2 | ST. LOUIS, Oct. 23, 2013 (CRWE Press | karnacua2 | 10/23/2013 12:48:03 PM |
1 | Stereotaxis, Inc. (Nasdaq:STXS) STXS skyrocketed | karnacua2 | 10/23/2013 12:46:38 PM |